• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Unveiling immune features of heart failure paves the way for targeted therapies

Bioengineer by Bioengineer
April 24, 2024
in Health
Reading Time: 2 mins read
0
Graphical abstract summarizes the workflow and major findings of the study
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This study was led by Prof. Xiang Cheng (Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology). In this study, researchers employed single-cell RNA sequencing on cardiac immune cells from heart failure patients (ischemic cardiomyopathy and dilated cardiomyopathy) undergoing heart transplantation and from healthy donors. Transcriptomic characteristics associated with heart failure were identified. In addition to the bioinformatics analysis, experimental validations were conducted to further substantiate the reliability of the findings.

Graphical abstract summarizes the workflow and major findings of the study

Credit: ©Science China Press

This study was led by Prof. Xiang Cheng (Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology). In this study, researchers employed single-cell RNA sequencing on cardiac immune cells from heart failure patients (ischemic cardiomyopathy and dilated cardiomyopathy) undergoing heart transplantation and from healthy donors. Transcriptomic characteristics associated with heart failure were identified. In addition to the bioinformatics analysis, experimental validations were conducted to further substantiate the reliability of the findings.

Macrophages emerged as the most abundant immune cells in normal and failing hearts, with differential expression of genes related to tissue residency, inflammation and fibrosis. In normal human hearts, Mac-LYVE1 expressing resident macrophage-associated genes dominated the macrophage population, but their proportion decreased in failing hearts. In contrast, Mac-IL1β, which surged significantly in failing hearts, exhibited high expression of genes linked to proinflammatory and antigen-presenting function.

Heart samples from patients with heart failure are typically unavailable for clinical assessment, posing a challenge to directly evaluating cardiac inflammation. Inflammatory biomarkers signaling cardiac inflammation have emerged as a viable alternative approach. In this study, a multi-biomarker profiling utilizing complement C1q, complement factor D, cystatin C, progranulin, and galectin-3 demonstrated promising potential as reliable indicators of cardiac inflammation in heart failure.

Chemokine receptor analysis plays a crucial role in unraveling the mechanisms of immune cell migration, which is of great significance for immunotherapies. A key finding of this research is the upregulation of CXCR4 in myeloid cell clusters within failing hearts compared to those in normal hearts. The CXCL12/CXCR4 axis potentially orchestrates the recruitment of myeloid cells to failing hearts, highlighting it as a promising therapeutic target for addressing heart failure.

Additionally, drug prediction analysis revealed drugs that potentially target myeloid cell subpopulations associated with heart failure, some of which have demonstrated potential efficacy in impeding the progression of heart failure.

###

See the article:

Global characterization of myeloid cells in the human failing heart

https://doi.org/10.1016/j.scib.2024.03.042



Journal

Science Bulletin

DOI

10.1016/j.scib.2024.03.042

Share12Tweet8Share2ShareShareShare2

Related Posts

TMolNet: Revolutionizing Molecular Property Prediction

September 21, 2025

NICU Families’ Stories Through Staff Perspectives

September 21, 2025

CT Scans in Kids: Cancer Risk Insights

September 20, 2025

Revealing Tendon Changes from Rotator Cuff Tears

September 20, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    156 shares
    Share 62 Tweet 39
  • Physicists Develop Visible Time Crystal for the First Time

    68 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Enterococcus faecium Infections in Mexican Children

Enhanced Copper Detection with Iron Oxide-Graphite Sensors

Micro-LEDs Drive Transparent, Free-Form, Near-Eye Displays

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.